In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.

Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over 2 h. In vitro susceptibility studies showed that the cefodizime spectrum includes all those Enterobacteriaceae, staphylococci, Streptococcus spp., Haemophilus spp., and N...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jones, R N, Barry, A L, Thornsberry, C, Wilson, H W
Format: Artigo
Idioma:Inglês
Publicat: 1981
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC181795/
https://ncbi.nlm.nih.gov/pubmed/6275785
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars